XML 34 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock based compensation (Tables)
3 Months Ended
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation cost recognized for all stock-based compensation awards

Total compensation cost recognized for all stock‑based compensation awards in the statements of operations and comprehensive loss is as follows:

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

    

2017

    

2016

 

 

 

(in thousands)

 

Research and development

 

$

1,258

 

$

1,117

 

General and administrative

 

 

907

 

 

305

 

Total stock-compensation expense

 

$

2,165

 

$

1,422

 

 

Summary of status and changes in unvested restricted stock

A summary of the status of and changes in unvested restricted stock unit activity under the Company’s equity award plan was as follows:

 

 

 

 

 

 

 

 

 

 

    

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

 

 

 

 

 

Fair Value

 

 

    

Shares

    

Per Share

 

Unvested restricted common stock as of December 31, 2016

 

1,167,984

 

$

0.76

 

Issued

 

 —

 

 

 —

 

Vested

 

(153,685)

 

$

0.76

 

Repurchased

 

(17,157)

 

$

0.51

 

Unvested restricted common stock as of March 31, 2017

 

997,142

 

$

0.74

 

 

Summary of status and changes in stock options

The following is a summary of stock option activity for the three months ended March 31, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Weighted

    

Remaining

    

Aggregate

 

 

 

 

 

Average

 

Contractual

 

Intrinsic

 

 

 

 

 

Exercise

 

Life

 

Value

 

 

    

Shares

    

Price

    

(in years)

    

(in thousands)

 

Outstanding at December 31, 2016

 

1,871,237

 

$

10.21

 

 

 

 

 

 

Granted

 

1,043,800

 

$

11.94

 

 

 

 

 

 

Exercised

 

(70,938)

 

$

8.49

 

 

 

 

 

 

Cancelled or forfeited

 

(60,246)

 

$

9.93

 

 

 

 

 

 

Outstanding at March 31, 2017

 

2,783,853

 

$

10.91

 

8.9

 

$

6,858

 

Exercisable at March 31, 2017

 

511,643

 

$

9.30

 

8.0

 

 

2,075

 

Vested and expected to vest at March 31, 2017

 

2,783,853

 

$

10.91

 

8.9

 

$

6,858

 

 

Assumptions

The assumptions utilized to value the warrants to purchase equity securities as of March 31, 2017 and December 31, 2016 are as follows:

 

 

 

 

 

 

 

 

 

 

 

As of March 31, 

 

As of December 31, 

 

 

    

2017

    

2016

 

Risk-free interest rate

 

1.8

%  

 

1.8

%  

 

Expected dividend yield

 

 —

%

 

 —

%

 

Expected term (in years)

 

4.4

 

 

4.7

 

 

Expected volatility

 

86.7

%  

 

97.5

%  

 

 

Employees and directors stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Assumptions

The fair value of each option issued to employees and directors was estimated at the date of grant using the Black‑Scholes option pricing model with the following weighted‑average assumptions:

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

 

2017

    

2016

 

Risk-free interest rate

 

2.0

%  

 

1.5

%  

 

Expected dividend yield

 

 —

%

 

 —

%

 

Expected term (in years)

 

6.0

 

 

6.0

 

 

Expected volatility

 

73.6

%  

 

73.0

%  

 

 

Non-employees stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Assumptions

The fair value of each option issued to non‑employees was estimated at each vesting and reporting date using the Black‑Scholes option pricing model. The reporting date fair value was determined using the following weighted‑average assumptions:

 

 

 

 

 

 

 

 

 

 

As of March 31, 

 

 

 

2017

    

2016

 

Risk-free interest rate

 

2.0

%  

 

1.5

%  

 

Expected dividend yield

 

 —

%

 

 —

%

 

Expected term (in years)

 

8.7

 

 

10.0

 

 

Expected volatility

 

83.6

%  

 

84.1

%